TRAF interactions with raft‐like buoyant complexes, better than TRAF rates of degradation, differentiate signaling by CD40 and EBV latent membrane protein 1
Open Access
- 25 August 2004
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 113 (2) , 267-275
- https://doi.org/10.1002/ijc.20503
Abstract
The CD40 receptor and the Epstein‐Barr virus oncoprotein LMP1 are both members of the TNF‐receptor family and share several signaling mediators, including TRAF2 and TRAF3. Depending on the cell lineage and stage of maturation, LMP1 and CD40 can have synergistic, antagonist or unrelated effects. Previous publications have suggested that both TRAF2 and TRAF3 move into lipid rafts upon LMP1 expression or CD40 activation, whereas their proteolysis is only enhanced by CD40. However CD40‐induced proteolysis of TRAF2 has only been reported in murine cells, and there are conflicting data regarding translocation of TRAF2 into lipid rafts. We therefore investigated TRAF2 and TRAF3 modifications induced by CD40 and LMP1 signaling in a panel of human cell lines of lymphoid and epithelial origins. Upon CD40 stimulation, a marked redistribution of TRAF2 into the buoyant raft fraction was observed in all cell lines and was often associated with a similar redistribution of TRAF3. In contrast, only TRAF3 was redistributed into the raft fraction upon LMP1 expression. Moreover parallel changes in subcellular distribution of TRAF2 and TRAF3 were recorded by electron microscopy. A significant decrease in TRAF2 and TRAF3 concentrations triggered by CD40 ligation was observed in only 1 cell line and there was no evidence that this decrease was required for the negative feed‐back on JNK activation. TRAF2 redistribution into raft‐like complexes thus appears as the most significant event distinctive of CD40 and LMP1 signaling. On the other hand, the parallel influence of CD40 and LMP1 on TRAF3 redistribution is consistent with functional similarities between the CD40‐TRAF3 and LMP1‐TRAF3 axes.Keywords
This publication has 44 references indexed in Scilit:
- Elucidation of the c-Jun N-Terminal Kinase Pathway Mediated by Epstein-Barr Virus-Encoded Latent Membrane Protein 1Molecular and Cellular Biology, 2004
- Lipid RaftsCell, 2003
- Tumor Necrosis Factor Receptor-associated Factor 2 (TRAF2)-deficient B Lymphocytes Reveal Novel Roles for TRAF2 in CD40 SignalingJournal of Biological Chemistry, 2003
- TRAF1 Is a Critical Regulator of JNK Signaling by the TRAF-Binding Domain of the Epstein-Barr Virus-Encoded Latent Infection Membrane Protein 1 but Not CD40Journal of Virology, 2003
- Regulation of TRAF2 Signaling by Self-induced DegradationJournal of Biological Chemistry, 2002
- LMP1 structure and signal transductionSeminars in Cancer Biology, 2001
- Differential Requirements for Tumor Necrosis Factor Receptor-associated Factor Family Proteins in CD40-mediated Induction of NF-κB and Jun N-terminal Kinase ActivationJournal of Biological Chemistry, 1999
- Epstein–Barr virus latent membrane protein-1 (LMP1) signalling is distinct from CD40 and involves physical cooperation of its two C-terminus functional regionsOncogene, 1998
- IL-4 and anti-CD40 protect against Fasmediated B cell apoptosis and induce B cell growth and differentiationInternational Immunology, 1996
- Structure and regulation of the Blast-2/CD23 antigen in epithelial cells from nasopharyngeal carcinomaInternational Immunology, 1990